the Effect of Weight Bearing Status on Healing and Pain Outcomes After Surgery for Osteochondral Defects of the Ankle
NCT ID: NCT01405664
Last Updated: 2024-08-21
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
68 participants
INTERVENTIONAL
2011-09-01
2023-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The investigators hypothesize that their will be no difference in functional outcomes between weight bearing as tolerated as compared to non-weight bearing for six weeks after forage surgery for OCD of the ankle.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Effect of Weight Bearing on Patient Outcomes Following 1st MTP Joint Fusion
NCT04473196
Early Weightbearing and Mobilization Versus Non-Weightbearing and Mobilization in Unstable Ankle Fractures
NCT01196338
Early Protected Full Weight-bearing vs. Partial Weight-bearing After Surgical Fixation of Unstable Ankle Fractures, Monitored With Bio-feedback Insoles.
NCT06023979
Stability and Outcomes of Non-displaced Lisfranc Injuries
NCT04430101
Compression Therapy for Swelling Management Following Ankle Injury
NCT06772649
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Equivalent clinical outcomes to non-weight bearing; Similar radiographic findings on CT at follow-up visit between the two groups; reduced morbidity and disability to subjects through elimination of a period of non-weight bearing; reduction of cost to patients by eliminating need for adjuvant walking and mobility aids (crutches, taxis) and time off work.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Non-Weight Bearing x 6 weeks
No interventions assigned to this group
Immediate Weight-Bearing as Tolerated
Weight-Bearing as Tolerated
WBAT immediately after surgery
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Weight-Bearing as Tolerated
WBAT immediately after surgery
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* No prior ankle surgery
* Able and willing to comply with follow-up
* Capable of provide informed consent
* Medically fit for surgery
* Lesions on preoperative CT Scan \< 1.5cm
* Symptomatic (ie:pain, restricted activities, inability to WB, decreased ROM)
* Single Isolated lesion
* Failure of conservative treatment (3 months of limited activities and/or weight bearing and/or immobilization)
Exclusion Criteria
* Inflammatory arthritis
* Diffuse osteoarthritis of affected joint
* Associated fracture
* Prior ankle surgery for current injury (including arthroscopy)
* Unable to comply with follow-up
* Unable to provide informed consent
* Bernt \& Hardy class IV (amenable to ORIF)
* Multiple osteochondral defects in one ankle or touching osteochondral lesions of tibia and talus
* Prior osteochondral defects of the affected ankle
16 Years
65 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Nova Scotia Health Authority
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Mark Glazebrook, MD,FRCSC
Role: PRINCIPAL_INVESTIGATOR
Nova Scotia Health Authority
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Queen Elizabeth II Health Sciences Centre, Halifax Infirmary
Halifax, Nova Scotia, Canada
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
WBOCD
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.